Morgan Pantuck

Cornell University

Papers

1

Total Citations

5

H-Index

1

About

Morgan Pantuck is a clinical researcher whose work centers on advancing minimally invasive diagnostic techniques in urologic oncology, with a particular focus on prostate cancer detection. Their major contribution lies in pioneering the in-office, transperineal MRI/ultrasound software fusion targeted prostate biopsy—a procedure that combines precision imaging with local anesthesia to improve patient comfort and diagnostic accuracy while reducing infection risk. Pantuck’s 2019 study, published as part of the IDEAL Stage 2a framework, provided critical early evidence for the feasibility and safety of this approach, demonstrating that targeted biopsies could be performed effectively outside the operating room. This work has garnered 5 citations, reflecting its foundational role in shaping outpatient urologic practice. By bridging the gap between advanced imaging technology and practical, patient-centered care, Pantuck has helped pave the way for broader adoption of transperineal biopsy protocols. Their research continues to influence clinical guidelines and offers a compelling model for integrating innovation with accessibility in cancer diagnostics.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
IDEAL Stage 2a experience with in-office, transperineal MRI/ultrasound software fusion targeted prostate biopsy
5 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Cornell University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago